These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35513291)

  • 21. Computational analysis and verification of molecular genetic targets for glioblastoma.
    Xue L; Liu H; Chen Y; Wei L; Hong J
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32469390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
    Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
    Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secreted Phosphoprotein 1 (SPP1) and Fibronectin 1 (FN1) Are Associated with Progression and Prognosis of Esophageal Cancer as Identified by Integrated Expression Profiles Analysis.
    Li M; Wang K; Pang Y; Zhang H; Peng H; Shi Q; Zhang Z; Cui X; Li F
    Med Sci Monit; 2020 Mar; 26():e920355. PubMed ID: 32208405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway.
    Liao YX; Zhang ZP; Zhao J; Liu JP
    Cell Physiol Biochem; 2018; 48(3):1382-1396. PubMed ID: 30048971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
    Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z
    Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis.
    Yu C; Yin J; Wang X; Chen L; Wei Y; Lu C; You Y
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32412599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis.
    Li Y; Min W; Li M; Han G; Dai D; Zhang L; Chen X; Wang X; Zhang Y; Yue Z; Liu J
    Int J Mol Med; 2016 Oct; 38(4):1170-8. PubMed ID: 27572852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying
    Ding J; Liu Y; Lai Y
    PeerJ; 2020; 8():e10419. PubMed ID: 33282565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Systems Level Molecular Signatures from Glioblastoma Multiforme Derived Extracellular Vesicles.
    Roy N; Gaikwad M; Bhattacharrya DK; Barah P
    J Mol Neurosci; 2021 Jun; 71(6):1156-1167. PubMed ID: 33231813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme.
    Liu E; Li W; Jian LP; Yin S; Yang S; Zhao H; Huang W; Zhang Y; Zhou H
    Transl Oncol; 2023 Oct; 36():101739. PubMed ID: 37544033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a key glioblastoma candidate gene, FUBP3, based on weighted gene co-expression network analysis.
    Li J; Zhang Z; Guo K; Wu S; Guo C; Zhang X; Wang Z
    BMC Neurol; 2022 Apr; 22(1):139. PubMed ID: 35413821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioinformatics analysis of high-throughput data to validate potential novel biomarkers and small molecule drugs for glioblastoma multiforme.
    Qi F; Li Q; Lu X; Chen Z
    J Int Med Res; 2020 Jul; 48(7):300060520924541. PubMed ID: 32634050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Potential Biomarkers for Thyroid Cancer Using Bioinformatics Strategy: A Study Based on GEO Datasets.
    Shen Y; Dong S; Liu J; Zhang L; Zhang J; Zhou H; Dong W
    Biomed Res Int; 2020; 2020():9710421. PubMed ID: 32337286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 63 signature genes prediction system is effective for glioblastoma prognosis.
    Zhang Y; Xu J; Zhu X
    Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated Transcriptome Profiling Identifies Prognostic Hub Genes as Therapeutic Targets of Glioblastoma: Evidenced by Bioinformatics Analysis.
    Nayak C; Singh SK
    ACS Omega; 2022 Jul; 7(26):22531-22550. PubMed ID: 35811900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme.
    Yang J; Wang L; Xu Z; Wu L; Liu B; Wang J; Tian D; Xiong X; Chen Q
    Front Genet; 2020; 11():253. PubMed ID: 32296458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Crucial Candidate Genes and Pathways in Glioblastoma Multiform by Bioinformatics Analysis.
    Alshabi AM; Vastrad B; Shaikh IA; Vastrad C
    Biomolecules; 2019 May; 9(5):. PubMed ID: 31137733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the potential biomarkers for prognosis of glioblastoma via weighted gene co-expression network analysis.
    Zhang M; Zhou Z; Liu Z; Liu F; Zhao C
    PeerJ; 2022; 10():e12768. PubMed ID: 35111402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of six candidate genes for endometrial carcinoma by bioinformatics analysis.
    Zhu Y; Shi L; Chen P; Zhang Y; Zhu T
    World J Surg Oncol; 2020 Jul; 18(1):161. PubMed ID: 32641130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.